Phase I Dose-Escalation Study of 5-Day Intermittent Oral...

Journal of Clinical Oncology 2014 / 05 Vol. 32; Iss. 14

Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer

Chien, A. J., Munster, P. N., Melisko, M. E., Rugo, H. S., Park, J. W., Goga, A., Auerback, G., Khanafshar, E., Ordovas, K., Koch, K. M., Moasser, M. M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2013.52.1161
Date:
May, 2014
File:
PDF, 449 KB
english, 2014
Conversion to is in progress
Conversion to is failed